Saitama, Japan

Tomohiro Sugimoto

This inventor holds 16 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Canon Kabushiki Kaisha, Taisho Pharmaceutical Co., Ltd., Meiji Seika Pharma Co., Ltd.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohiro Sugimoto. Retrieved from https://idiyas.com/inventor/tomohiro-sugimoto-kviob2sb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 37.5

 

Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Omiya, JP (2000 - 2001)
  • Tokyo, JP (2001)
  • Minamisaitama-gun, JP (2012 - 2013)
  • Saitama, JP (2012 - 2015)
  • Yoshikawa, JP (2013 - 2022)

Company Filing History:


Years Active: 2000-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovations of Tomohiro Sugimoto

Introduction

Tomohiro Sugimoto is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing macrolide compounds. With a total of 16 patents to his name, Sugimoto's work has been instrumental in addressing antibiotic resistance.

Latest Patents

Among his latest patents is the "C-4″ position substituted macrolide derivative." This macrolide compound is effective against erythromycin-resistant bacteria, including resistant pneumococci, streptococci, and mycoplasmas. Another notable patent is the "10a-azalide compound having a 4-membered ring structure." This compound features a 4-membered ring structure crosslinked at the 10- and 12-positions, making it effective against erythromycin-resistant bacteria as well.

Career Highlights

Throughout his career, Sugimoto has worked with reputable companies such as Taisho Pharmaceutical Co., Ltd. and Meiji Seika Pharma Co., Ltd. His innovative research and development efforts have contributed to advancements in antibiotic therapies.

Collaborations

Some of his notable coworkers include Masato Kashimura and Kanako Yamamoto. Their collaborative efforts have further enhanced the impact of Sugimoto's inventions in the pharmaceutical industry.

Conclusion

Tomohiro Sugimoto's contributions to the field of pharmaceuticals through his innovative patents highlight the importance of addressing antibiotic resistance. His work continues to influence the development of effective treatments for resistant bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…